CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,508,583 | -25.0% | 6,595,801 | 0.0% | 0.23% | -27.5% |
| Q2 2023 | $11,344,778 | +13.9% | 6,595,801 | 0.0% | 0.32% | -13.2% |
| Q1 2023 | $9,959,660 | -5.6% | 6,595,801 | 0.0% | 0.36% | -18.2% |
| Q4 2022 | $10,553,282 | +10.3% | 6,595,801 | 0.0% | 0.44% | +12.7% |
| Q3 2022 | $9,564,000 | -10.0% | 6,595,801 | +13.6% | 0.40% | -23.0% |
| Q2 2022 | $10,621,000 | -31.5% | 5,803,700 | 0.0% | 0.51% | -17.3% |
| Q1 2022 | $15,496,000 | -38.3% | 5,803,700 | 0.0% | 0.62% | -32.0% |
| Q4 2021 | $25,130,000 | -41.7% | 5,803,700 | +4.1% | 0.91% | -43.6% |
| Q1 2021 | $43,106,000 | +18.0% | 5,576,471 | 0.0% | 1.62% | +12.5% |
| Q4 2020 | $36,526,000 | +54.3% | 5,576,471 | +56.7% | 1.44% | +11.5% |
| Q3 2020 | $23,672,000 | -8.8% | 3,559,722 | +14.3% | 1.29% | -19.4% |
| Q2 2020 | $25,952,000 | -13.7% | 3,115,537 | -20.6% | 1.60% | -42.9% |
| Q1 2020 | $30,082,000 | +372.5% | 3,921,973 | +411.9% | 2.80% | +480.5% |
| Q4 2019 | $6,367,000 | -54.0% | 766,148 | -59.2% | 0.48% | -66.8% |
| Q3 2019 | $13,853,000 | -34.1% | 1,877,148 | +0.2% | 1.46% | -36.6% |
| Q2 2019 | $21,022,000 | +63.2% | 1,873,617 | +56.4% | 2.30% | +59.2% |
| Q1 2019 | $12,879,000 | -45.7% | 1,198,000 | +6.5% | 1.44% | -49.6% |
| Q4 2017 | $23,738,000 | -41.4% | 1,124,483 | -49.6% | 2.86% | -44.4% |
| Q3 2017 | $40,535,000 | +29.0% | 2,230,898 | +10.1% | 5.15% | +5.6% |
| Q2 2017 | $31,418,000 | +0.8% | 2,026,998 | +12.3% | 4.88% | -8.0% |
| Q1 2017 | $31,167,000 | +411.2% | 1,804,675 | +225.3% | 5.30% | +332.7% |
| Q4 2016 | $6,097,000 | -34.3% | 554,806 | -6.3% | 1.22% | -30.0% |
| Q3 2016 | $9,280,000 | +49.9% | 591,813 | -2.4% | 1.75% | +32.6% |
| Q2 2016 | $6,192,000 | -20.8% | 606,138 | 0.0% | 1.32% | -31.8% |
| Q1 2016 | $7,819,000 | -38.5% | 606,138 | -0.4% | 1.94% | -10.7% |
| Q4 2015 | $12,707,000 | – | 608,848 | – | 2.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |